Loading the SOTA2 catalog…
INTDose
FDA 510(k)-cleared (K213137) Monte Carlo 3-D independent dose verification.
What is INTDose?
FDA 510(k)-cleared (K213137) Monte Carlo 3-D independent dose verification. TPS-neutral second check using in-house virtual source models — validated within 1% of Varian Gold beam data. Supports Varian conventional linacs, Halcyon, and TomoTherapy. Photons: 3DCRT, IMRT, VMAT.
Product typeHealthcare Data & Research
Pricing · Per Seat
DeploymentOn-premises
APINot available
What teams use INTDose for
Clinical research data curation
Radiation oncology treatment planning and QA
Brain ventricle volumetrics for hydrocephalus
Rankings
Appears in these rankings
Integrations and access
Platforms, integrations, and language support vary by plan and region. Confirm final requirements with the vendor.
Platforms
IntegrationsAPI and webhooks
Languages
Support
What reviewers say
Community reviewsReviews are owned and editable by their authors.
Sign in to reviewLoading community reviews…
Enterprise readiness
Compliance claims are normalized from current vendor documentation and independently reviewed by SOTA2.
FDA 510(k) - INTContour
FDA 510(k) - INTDose
On-premise by default — every product installs inside the institution's network; no cloud component carries PHI
No outbound PHI — no telemetry, no auto-update over the internet, no patient data crosses the firewall
Audit-ready — every transformation is logged; re-identification linking files stay on customer storage
Software delivered to local computers with no retained remote access unless requested
Locally installed products collect no data without user acknowledgement or permissions
Data retention:
Benchmarks and comparisons
Independent benchmarksStructured task results are being verified.
Side-by-side comparisonsComparison workspaces will be available in a later release.
